Plexium Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
52
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$60.1M
- Investors
-
17
Plexium General Information
Description
Developer of protein-degrading therapeutics designed to treat cancer and other serious diseases. The company identifies novel small molecules that redirect ligases to targets of interest or induce degradation of targets by directly binding to them, enabling the medical community to combat cancer and inflammatory diseases in an improved manner.
Contact Information
Website
www.plexium.comCorporate Office
- 9330 Scranton Road
- Suite 500
- San Diego, CA 92121
- United States
Corporate Office
- 9330 Scranton Road
- Suite 500
- San Diego, CA 92121
- United States
Plexium Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series C) | 25-Aug-2025 | $60.1M | Completed | Clinical Trials - Phase 1 | ||
| 3. Later Stage VC (Series B) | 28-Feb-2022 | Completed | Clinical Trials - Phase 1 | |||
| 2. Early Stage VC (Series A) | 21-Jan-2021 | $63M | $63M | Completed | Clinical Trials - Phase 1 | |
| 1. University Spin-Out | 01-Jan-2017 | Completed | Startup |
Plexium Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 67,584,764 | $0.000010 | $0.04 | $0.04 | 1x | $0.04 | 2.48% | |
| Series A | 274,051,339 | $0.000010 | $0.07 | $0.07 | 1x | $0.07 | 10.04% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Plexium Comparisons
Industry
Financing
Details
Plexium Competitors (43)
One of Plexium’s 43 competitors is Centrose, a Venture Capital-Backed company based in Madison, WI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Centrose | Venture Capital-Backed | Madison, WI | ||||
| ImmunoGenesis | Venture Capital-Backed | Houston, TX | ||||
| Arvinas | Formerly VC-backed | New Haven, CT | ||||
| Apexian Pharmaceuticals | Venture Capital-Backed | Indianapolis, IN | ||||
| Citryll | Venture Capital-Backed | Oss, Netherlands |
Plexium Patents
Plexium Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026174209-A2 | Ikzf2 positive biomarkers in cancer treatment | Pending | 14-Feb-2025 | ||
| WO-2026136588-A1 | Degraders of swi/snf-related matrix-associated actin-dependent regulator of chromatin subfamily a | Pending | 18-Dec-2024 | ||
| WO-2026102277-A1 | Combination therapies comprising ikzf2 degrader compounds | Pending | 08-Nov-2024 | ||
| WO-2026064643-A1 | Compounds, compositions, and methods of use thereof | Pending | 20-Sep-2024 | ||
| AU-2024376167-A1 | Compounds and pharmaceutical compositions that degrade swi/snf-related matrix-associated actin-dependent regulator of chromatin subfamily a | Pending | 10-Nov-2023 | C07D487/04 |
Plexium Signals
Plexium Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| aMoon Fund | Venture Capital | Minority | ||
| BVF Partners | Hedge Fund | Minority | ||
| Pappas Capital | Venture Capital | Minority | ||
| RA Capital Management | Asset Manager | Minority | ||
| SoftBank Investment Advisers | Growth/Expansion | Minority |
Plexium FAQs
-
When was Plexium founded?
Plexium was founded in 2017.
-
Where is Plexium headquartered?
Plexium is headquartered in San Diego, CA.
-
What is the size of Plexium?
Plexium has 52 total employees.
-
What industry is Plexium in?
Plexium’s primary industry is Drug Discovery.
-
Is Plexium a private or public company?
Plexium is a Private company.
-
What is the current valuation of Plexium?
The current valuation of Plexium is .
-
What is Plexium’s current revenue?
The current revenue for Plexium is .
-
How much funding has Plexium raised over time?
Plexium has raised $225M.
-
Who are Plexium’s investors?
aMoon Fund, BVF Partners, Pappas Capital, RA Capital Management, and SoftBank Investment Advisers are 5 of 17 investors who have invested in Plexium.
-
Who are Plexium’s competitors?
Centrose, ImmunoGenesis, Arvinas, Apexian Pharmaceuticals, and Citryll are some of the 43 competitors of Plexium.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process